The approval covers 2 mg/pen and 4 mg/pen strengths at 1.34 mg/mL matching the commercially available Ozempic presentations and has no fixed expiry date, meaning it is a durable commercial authorisation rather than a temporary or provisional approval
Unlike surgery, which is a one-time procedure, medication requires ongoing prescriptions, GP oversight, and out-of-pocket cost indefinitely
The warmed medication causes less vasoconstriction in subcutaneous tissue, reducing the sharp stinging sensation some patients experience with cold injections
Missing one weekly injection delays your next dose by one week to prevent accidental double-dosing
Protect renal tissue from oxidative stress and inflammation
M., Crispie, F., van Leuven, L., Lyte, J